Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.59% |
| 2 | Technology | 20.43% |
| 3 | Financials | 12.09% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Healthcare | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Vanguard FTSE Europe ETF
VGK
$29.8B
| $1.27B | 0.09% |
18,030,134
+3,697,961
| +26% | +$255M |
2013 Q2
47 quarters
|
|
202
Nike
NKE
$55B
| $1.26B | 0.09% |
19,835,324
-860,473
| -4% | -$63.3M |
2013 Q2
47 quarters
|
|
203
iShares Core S&P Total US Stock Market ETF
ITOT
$95.9B
| $1.26B | 0.09% |
10,297,404
-230,680
| -2% | -$29.7M |
2013 Q2
47 quarters
|
|
204
Roblox
RBLX
$35.4B
| $1.25B | 0.09% |
21,489,179
-4,254,919
| -17% | -$267M |
2021 Q1
16 quarters
|
|
205
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.1B
| $1.25B | 0.09% |
15,257,496
-396,595
| -3% | -$32.1M |
2013 Q2
47 quarters
|
|
206
SLB Ltd
SLB
$73.4B
| $1.25B | 0.09% |
29,842,282
+4,177,937
| +16% | +$171M |
2013 Q2
47 quarters
|
|
207
Broadridge
BR
$19.6B
| $1.23B | 0.09% |
5,088,843
-66,455
| -1% | -$15.6M |
2013 Q2
47 quarters
|
|
208
Air Products & Chemicals
APD
$66.2B
| $1.23B | 0.09% |
4,164,431
+337,232
| +9% | +$104M |
2013 Q2
47 quarters
|
|
209
CVS Health
CVS
$119B
| $1.22B | 0.09% |
17,933,629
+375,565
| +2% | +$22.5M |
2013 Q2
47 quarters
|
|
210
Illinois Tool Works
ITW
$77.4B
| $1.2B | 0.09% |
4,843,741
+338,944
| +8% | +$87.1M |
2013 Q2
47 quarters
|
|
211
Cigna
CI
$79.7B
| $1.19B | 0.08% |
3,604,818
-248,760
| -6% | -$74.9M |
2013 Q2
47 quarters
|
|
212
Cummins
CMI
$73.3B
| $1.18B | 0.08% |
3,779,980
+113,397
| +3% | +$39.9M |
2013 Q2
47 quarters
|
|
213
State Street Industrial Select Sector SPDR ETF
XLI
$30.5B
| $1.18B | 0.08% |
9,005,182
+251,253
| +3% | +$34M |
2013 Q2
47 quarters
|
|
|
214
Intel
INTC
$477B
| $1.18B | 0.08% |
51,892,077
-53,661,741
| -51% | -$1.17B |
2013 Q2
47 quarters
|
|
215
Travelers Companies
TRV
$81.2B
| $1.17B | 0.08% |
4,438,785
-9,190
| -0.2% | -$2.29M |
2013 Q2
47 quarters
|
|
216
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $1.17B | 0.08% |
14,924,043
+260,579
| +2% | +$20.2M |
2013 Q2
47 quarters
|
|
217
Crown Castle
CCI
$35.1B
| $1.16B | 0.08% |
11,148,628
-920,920
| -8% | -$86M |
2013 Q2
47 quarters
|
|
218
AstraZeneca
AZN
$256B
| $1.16B | 0.08% |
7,884,268
-766,277
| -9% | -$111M |
2013 Q2
47 quarters
|
|
219
Cheniere Energy
LNG
$59.3B
| $1.16B | 0.08% |
5,006,633
+100,847
| +2% | +$22.7M |
2013 Q2
47 quarters
|
|
220
US Bancorp
USB
$91.1B
| $1.15B | 0.08% |
27,312,475
+1,074,874
| +4% | +$49.6M |
2013 Q2
47 quarters
|
|
221
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.5B
| $1.15B | 0.08% |
22,560,058
-429,964
| -2% | -$21.8M |
2013 Q4
45 quarters
|
|
222
HDFC Bank
HDB
$122B
| $1.15B | 0.08% |
34,564,530
-14,947,408
| -30% | -$456M |
2013 Q2
47 quarters
|
|
223
iShares Core Dividend Growth ETF
DGRO
$43.9B
| $1.15B | 0.08% |
18,545,534
+133,038
| +0.7% | +$8.34M |
2014 Q3
42 quarters
|
|
224
Vanguard Tax-Exempt Bond Index Fund
VTEB
$50.4B
| $1.14B | 0.08% |
23,002,421
+9,156,432
| +66% | +$458M |
2016 Q2
35 quarters
|
|
225
ASML
ASML
$635B
| $1.14B | 0.08% |
1,716,309
-961,136
| -36% | -$699M |
2013 Q2
47 quarters
|
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 407 new, 3,433 increased, 3,304 reduced and 268 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 407 new positions and closed 268 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.